Lee's Pharmaceutical Holdings Limited provided earnings guidance for the year ended December 31, 2018. The company anticipated that the unaudited net profit attributable to the Shareholders for the year ended 31 December 2018 will increase by about 50%, as compared to that of for the year ended 31 December 2017. The net profit increase was primarily due to a non-recurring gain recognized from the deemed disposal of interests in CVie Therapeutics Limited in December 2018.